Cargando…

In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer

SIMPLE SUMMARY: Endometrial cancer (EC) mortality is directly associated with the presence of poor prognostic factors. Molecular prognostic factors have been identified, but none are used in clinical practice due to lack of validation studies. This study aims to validate a set of 255 prognostic biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coll-de la Rubia, Eva, Martinez-Garcia, Elena, Dittmar, Gunnar, Nazarov, Petr V., Bebia, Vicente, Cabrera, Silvia, Gil-Moreno, Antonio, Colás, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534093/ https://www.ncbi.nlm.nih.gov/pubmed/34680205 http://dx.doi.org/10.3390/cancers13205052

Ejemplares similares

Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis
por: Coll-de la Rubia, Eva, et al.
Publicado: (2020)

Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis
por: Martinez-Garcia, Elena, et al.
Publicado: (2023)

Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool
por: Villafranca-Magdalena, Beatriz, et al.
Publicado: (2022)

Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
por: Altadill, Tatiana, et al.
Publicado: (2017)

Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018)

Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples
por: Martinez-Garcia, Elena, et al.
Publicado: (2016)

Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer
por: Megino-Luque, Cristina, et al.
Publicado: (2020)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020)

Potential strategies for prevention of tumor spillage in minimally invasive radical hysterectomy
por: Bebia, Vicente, et al.
Publicado: (2020)

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
por: Herrero, Carolina, et al.
Publicado: (2019)

Modeling Endometrial Cancer: Past, Present, and Future
por: Van Nyen, Tom, et al.
Publicado: (2018)

The Prognostic Role of LRIG Proteins in Endometrial Cancer
por: Razumova, Zoia, et al.
Publicado: (2021)

L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
por: Smogeli, Elisabeth, et al.
Publicado: (2016)

Postoperative Radiotherapy for Endometrial Cancer in Elderly (≥80 Years) Patients: Oncologic Outcomes, Toxicity, and Validation of Prognostic Scores
por: Meixner, Eva, et al.
Publicado: (2021)

Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools
por: Besso, María josé, et al.
Publicado: (2020)

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
por: Mota, Alba, et al.
Publicado: (2022)

Unveiling the potential effects of acetylsalicylic acid: insights into regeneration in endometrial stem cells
por: Park, Se-Ra, et al.
Publicado: (2023)

Unveiling the Potential of BenzylethyleneAryl–Urea Scaffolds for the Design of New Onco Immunomodulating Agents
por: Gil-Edo, Raquel, et al.
Publicado: (2023)

Construction and Validation of a Ferroptosis-Related Prognostic Model for Endometrial Cancer
por: Wang, Hao, et al.
Publicado: (2021)

In silico Screening Unveil the Great Potential of Ruminal Bacteria Synthesizing Lasso Peptides
por: Sabino, Yasmin Neves Vieira, et al.
Publicado: (2020)

The SuperChooz Experiment: Unveiling the Opportunity
por: CABRERA, Anatael
Publicado: (2022)

Development and validation of m6A regulators’ prognostic significance for endometrial cancer
por: Pang, Xuecheng, et al.
Publicado: (2021)

In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor
por: Ariey‐Bonnet, Jeremy, et al.
Publicado: (2020)

In Silico Approaches: A Way to Unveil Novel Therapeutic Drugs for Cervical Cancer Management
por: Gomes, Diana, et al.
Publicado: (2021)

Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach
por: Veerasamy, Ravichandran, et al.
Publicado: (2022)

Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer
por: Cabrera, Silvia, et al.
Publicado: (2023)

MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific in Silico Prognostic Biomarker Validation
por: Yip, Shun H., et al.
Publicado: (2019)

Development and Validation of a 5-Gene Autophagy-Based Prognostic Index in Endometrial Carcinoma
por: Chen, Xiaoyan, et al.
Publicado: (2021)

A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation
por: Yang, Xiao, et al.
Publicado: (2021)

Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics
por: Yu, Zhicheng, et al.
Publicado: (2021)

EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer
por: Roman-Canal, Berta, et al.
Publicado: (2019)

RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples
por: Nazarov, Petr V., et al.
Publicado: (2017)

Unveiling Distribution Patterns of Freshwater Phytoplankton by a Next Generation Sequencing Based Approach
por: Eiler, Alexander, et al.
Publicado: (2013)

Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
por: Jové, Mariona, et al.
Publicado: (2016)

Experimental and In Silico Analysis of Cordycepin and its Derivatives as Endometrial Cancer Treatment
por: Fong, Pedro, et al.
Publicado: (2019)

Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
por: Azuaje, Francisco, et al.
Publicado: (2019)

Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients
por: Nazarov, Petr V., et al.
Publicado: (2019)

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
por: Reijnen, Casper, et al.
Publicado: (2020)

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways
por: Besso, María José, et al.
Publicado: (2019)

Unveiling combinatorial regulation through the combination of ChIP information and in silico cis-regulatory module detection
por: Sun, Hong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7g16ugcs1qgkhin7u2m3ftfev9